Last reviewed · How we verify
NCT05528042: COBOX
Validation of the Performance of the COBOX Solution for Measuring Heart Rate and Respiratory Rate
NA trial testing Heart rate and respiratory rate measurement in Anyone Who Meets the Eligibility Criteria Can Use the Software in 323 participants. Status unknown.
19 September 2022
Quick facts
| Lead sponsor | Quantiq.io |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 323 |
| Start date | 9 September 2022 |
| Primary completion | 19 September 2022 |
| Estimated completion | 19 September 2022 |
Drugs / interventions tested
- Heart rate and respiratory rate measurement
Conditions studied
- Anyone Who Meets the Eligibility Criteria Can Use the Software — all drugs for Anyone Who Meets the Eligibility Criteria Can Use the Software →
Sponsor
Quantiq.io
Who can join
18 and older, any sex, with Anyone Who Meets the Eligibility Criteria Can Use the Software. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Quantiq.io "COBOX" is a software as a medical device. It relies on remote photoplethysmography, allowing for the remote measurement of a patient's physiological parameters from a healthcare professional's or patient's device which can be a smartphone, a computer or a health station with an optical camera. Quantiq.io software is a medical device which is : contactless for the measurement non-invasive for the patient In order to meet safety and quality standards, new health technologies require rigorous clinical validation with measurement performance at least equivalent to that of one CE marking measure device. In this context, we assume that the COBOX device will take measurements of heart and respiratory rates equivalent to those taken by medical devices and current practices.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05528042
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05528042 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Quantiq.io
- Last refreshed: 6 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05528042.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing